Recurrent Small Intestinal Carcinoma

1 clinical trials · Condition

Record	Firm	Date
Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT02949219)	Academic and Community Cancer Research United	2017-03-24

Every clearance here is in the API, with alerts when new ones post.